focus -WSS

focus

author：leisure time 2025-10-02 19:21:08 - browse：19391

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： UHS says company favors patients whose insurance pays more

focus

WSS

New lawsuit accuses health insurer Cigna of denying claims in bulk

Medicare solvency divides Republicans at the presidential debate

Rise in cancer among younger people worries and puzzles doctors

In the gardens at Boston Children's Hospital, families find sanctuary

Search called off for baby washed away in Pennsylvania flash flood

Senate panel clears PBM, hopsital reforms

focus

focus

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Sanofi CEO defends move to abandon profit guidance, boost research

BioMarin wins approval for gene therapy to treat hemophilia A

Rise in cancer among younger people worries and puzzles doctors

Trump demands the U.S. pay no more for drugs than other countries … again

The Sacklers, horror, and ‘The Fall of the House of Usher’

Bright Health sells Medicare Advantage business to Molina

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT Executive Editor Rick Berke on STAT's 8th birthday

focus

More doctors should go into startup world

What it's like to live with paralysis for one psychologist

Truvian presents data for its desktop blood

Removing probiotics from the NICU could threaten preemies' health

Why patients can’t get everything they want on drug pricing

UHS says company favors patients whose insurance pays more

focus

focus

knowledge

entertainment